We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

148 hedge funds and large institutions have $753M invested in Viking Therapeutics in 2018 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 53 increasing their positions, 31 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 21

151% more capital invested

Capital invested by funds: $300M → $753M (+$453M)

71% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 31

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

28% more funds holding

Funds holding: 116 → 148 (+32)

7.55% more ownership

Funds ownership: 53.84% → 61.39% (+7.6%)

4% less call options, than puts

Call options by funds: $35.3M | Put options by funds: $37M

Holders
148
Holders Change
+32
Holders Change %
+27.59%
% of All Funds
3.38%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
54
Increased
53
Reduced
31
Closed
21
Calls
$35.3M
Puts
$37M
Net Calls
-$1.64M
Net Calls Change
-$3.74M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$86M
2
State Street
State Street
Massachusetts
+$63.3M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$13.7M
4
PWAM
Park West Asset Management
California
+$10.2M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$9.99M

Top Sellers

1
ACA
Avoro Capital Advisors
New York
-$42.4M
2
BC
Boxer Capital
California
-$35.6M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$13.9M
4
ACP
Acuta Capital Partners
California
-$7.12M
5
OM
Opaleye Management
Massachusetts
-$4.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$126M +$86M +7,224,913 New
State Street
2
State Street
Massachusetts
$105M +$63.3M +5,321,983 +727%
BlackRock
3
BlackRock
New York
$58.4M +$4.89M +411,256 +14%
Vanguard Group
4
Vanguard Group
Pennsylvania
$50.1M +$6.05M +508,097 +21%
ACH
5
ArrowMark Colorado Holdings
Colorado
$50M +$13.7M +1,147,105 +67%
PWAM
6
Park West Asset Management
California
$22.1M +$10.2M +855,000 +206%
Balyasny Asset Management
7
Balyasny Asset Management
Illinois
$19.1M +$9.99M +839,851 +329%
Citadel Advisors
8
Citadel Advisors
Florida
$16.5M +$6.03M +506,430 +114%
Janus Henderson Group
9
Janus Henderson Group
United Kingdom
$15.5M -$13.9M -1,168,844 -57%
SFM
10
Sphera Funds Management
Israel
$15M +$920K +77,303 +10%
OM
11
Opaleye Management
Massachusetts
$14.4M -$4.46M -375,000 -31%
EAM
12
Eventide Asset Management
Massachusetts
$13.8M +$9.4M +790,000 New
Northern Trust
13
Northern Trust
Illinois
$10.7M +$1.45M +122,118 +25%
Deutsche Bank
14
Deutsche Bank
Germany
$10.3M +$4.44M +372,890 +172%
NIP
15
Nicholas Investment Partners
California
$10.1M +$753K +63,237 +12%
Jennison Associates
16
Jennison Associates
New York
$9.5M +$6.49M +545,400 New
RI
17
RTW Investments
New York
$8.71M +$5.95M +500,000 New
DM
18
Deerfield Management
New York
$8.01M +$5.47M +460,000 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$7.93M +$703K +59,079 +15%
Group One Trading
20
Group One Trading
Illinois
$7.52M +$3.05M +256,658 +147%
BBA
21
Baker Bros. Advisors
New York
$7.4M +$5.06M +425,000 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$6.71M +$470K +39,455 +11%
Macquarie Group
23
Macquarie Group
Australia
$6.56M +$556K +46,700 +14%
Millennium Management
24
Millennium Management
New York
$6.43M -$4.42M -371,188 -50%
CCI
25
Columbus Circle Investors
$5.96M +$4.07M +342,253 New
1
2 3 4 5

VKTX Hedge Fund Activity: Q3 2018 in Review

148 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2018, worth a combined $753M — up 151% from $300M a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new VKTX positions and 21 closed out — a net gain of 33 holders — while 53 added to existing stakes and 31 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $86M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $42.4M sold.

  • 148 institutional investors held Viking Therapeutics (VKTX) as of Q3 2018, up from 116 in Q2 2018.
  • Funds reported $753M of Viking Therapeutics stock for Q3 2018, up 151% quarter-over-quarter.
  • 54 funds opened new Viking Therapeutics positions in Q3 2018 and 21 closed out, a net change of +33 holders.
  • The largest Viking Therapeutics buyer in Q3 2018 was Fidelity Investments, an estimated $86M added.
  • The largest Viking Therapeutics seller in Q3 2018 was Avoro Capital Advisors, an estimated $42.4M sold.

Based on aggregated 13F filings for Q3 2018.